Research ArticleOriginal Research
Prognostic Value of Plasma Human β-Defensin 2 Level on Short-Term Clinical Outcomes in Patients With Community-Acquired Pneumonia: A Preliminary Study
Song Liu, Li-Rong He, Wei Wang, Gui-Hua Wang and Zheng-Yi He
Respiratory Care April 2013, 58 (4) 655-661; DOI: https://doi.org/10.4187/respcare.01827
Song Liu
Department of Respiratory Medicine, Beijing Friendship Hospital, Capital Medical University, Beijing, People's Republic of China.
MD PhDLi-Rong He
Department of Respiratory Medicine, Beijing Friendship Hospital, Capital Medical University, Beijing, People's Republic of China.
MDWei Wang
Department of Respiratory Medicine, Beijing Friendship Hospital, Capital Medical University, Beijing, People's Republic of China.
MDGui-Hua Wang
Department of Respiratory Medicine, Beijing Friendship Hospital, Capital Medical University, Beijing, People's Republic of China.
MDZheng-Yi He
Department of Respiratory Medicine, Beijing Friendship Hospital, Capital Medical University, Beijing, People's Republic of China.
MD PhDIn this issue
Respiratory Care
Vol. 58, Issue 4
1 Apr 2013
Prognostic Value of Plasma Human β-Defensin 2 Level on Short-Term Clinical Outcomes in Patients With Community-Acquired Pneumonia: A Preliminary Study
Song Liu, Li-Rong He, Wei Wang, Gui-Hua Wang, Zheng-Yi He
Respiratory Care Apr 2013, 58 (4) 655-661; DOI: 10.4187/respcare.01827